Final report of a phase 2 clinical trial of lenalidomide monotherapy for patients with T-cell lymphoma-Reference-Cited by-同舟云学术

Final report of a phase 2 clinical trial of lenalidomide monotherapy for patients with T-cell lymphoma

Published:2014-10-29 Issue:5 Volume:121 Page:716-723
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Toumishey Ethan¹,Prasad Angeli²,Dueck Greg³,Chua Neil²,Finch Daygen³,Johnston James⁴,van der Jagt Richard⁵,Stewart Doug⁶,White Darrell⁷,Belch Andrew²,Reiman Tony¹⁸

Affiliation:

1. Department of Medicine; Dalhousie University; Saint John New Brunswick Canada

2. Department of Oncology; University of Alberta; Edmonton Alberta Canada

3. Medical Oncology; British Columbia Cancer Agency, Centre for the Southern Interior; Kelowna British Columbia Canada

4. Department of Medicine; University of Manitoba; Winnipeg Manitoba Canada

5. Department of Medicine; University of Ottawa; Ottawa Ontario Canada

6. Department of Medicine; University of Calgary; Calgary Alberta Canada

7. Department of Medicine; Dalhousie University; Halifax Nova Scotia Canada

8. Canadian Cancer Society Research Chair; University of New Brunswick; Fredericton New Brunswick Canada

Funder

Celgene

Alberta Cancer Foundation

Canadian Cancer Society

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.29103/fullpdf

Reference35 articles.

1. Interim report of a phase 2 clinical trial of lenalidomide for T-cell non-Hodgkin lymphoma;Dueck;Cancer,2010

2. Strategies for relapsed peripheral T-cell lymphoma: the tail that wags the curve;Lunning;J Clin Oncol,2013

3. Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors;Mak;J Clin Oncol,2013

4. Peripheral T-cell lymphomas: progress and challenges;Savage;Oncology Exchange,2012

5. Single agent lenalidomide in newly diagnosed multiple myeloma: a retrospective analysis;Baz;Leuk Lymphoma,2010

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Valproic Acid inhibits proliferation and promotes apoptosis of peripheral T cell lymphoma cells via the miRNA-3196/KCNK3 signaling axis;2024-07-16

2. Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma;Journal of Hematology & Oncology;2024-06-01

3. How I treat peripheral T-cell lymphomas;Russian journal of hematology and transfusiology;2024-03-19

4. Aggressive T‐cell lymphomas: 2024: Updates on diagnosis, risk stratification, and management;American Journal of Hematology;2024-02-02

5. Few and far between: clinical management of rare extranodal subtypes of mature T-cell and NK-cell lymphomas;Haematologica;2023-11-21